Purchase Short-Term Access

Do the Benefits of Prolonged Low-Molecular-Weight Heparin Treatment Outweigh the Harms in Hospitalized Patients Who Are Bedbound?
Annals of Internal Medicine 2010;153:I-50. doi:10.7326/0003-4819-153-1-201007060-00002

Purchase Online access to this article for 24 hours
Buy Now for $32.00
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.